匹兹堡睡眠质量指数
医学
失眠症
安慰剂
汉密尔顿焦虑量表
哈姆德
焦虑
多导睡眠图
随机对照试验
睡眠障碍
睡眠开始
原发性失眠
不利影响
精神科
内科学
睡眠质量
替代医学
病理
呼吸暂停
作者
Suzhen Chen,Zhi Xu,Yinghui Li,Tianyu Wang,Yingying Yue,Zhenghua Hou,Linlin You,Na Lu,Yingying Yin,Xiaoyun Liu,Liangliang Tan,Houcheng Ji,Yaoran Shi,Xiaoyun Xin,Wenhao Jiang,Yonggui Yuan
出处
期刊:Neuropsychiatric Disease and Treatment
[Dove Medical Press]
日期:2022-03-01
卷期号:Volume 18: 669-679
被引量:1
摘要
Shumian capsule (SMC) is a patent Chinese herbal medicine that can soothe the liver and relieves depression, quiet the spirit. Here, we aimed to investigate the efficacy of SMC for treating insomnia using both scales and polysomnography (PSG).A randomized, double-blind, placebo-controlled trial was performed. Twenty-six insomnia patients randomly received SMC (n = 11) or placebo (n = 15) for four weeks. Pittsburgh Sleep Quality Inventory (PSQI), Insomnia Severity Index (ISI), 9-items Patient Health Questionnaire (PHQ-9), 7-items Generalized Anxiety Disorder (GAD-7), 17-item Hamilton Depression Rating Scale (HAMD-17), and Hamilton Anxiety Rating Scale (HAMA) were applied at the baseline and the 2nd, 4th week after treatment. Treatment Emergent Symptom Scale was used to assess adverse reactions. We used PSG to record and analyze sleep features at baseline and after four weeks.PSQI, ISI, PHQ-9, HAMD-17, and HAMA scores decreased significantly after SMC treatment. Also, the total sleep time, rapid-eye-movement (REM) sleep latency, stage 2 sleep, deep sleep, REM sleep, and sleep efficiency improved significantly after SMC treatment. In the placebo group, the only significant change was the decrease of PHQ-9 at week-2. Furthermore, both SMC and placebo reported no adverse events.SMC could safely improve sleep quality with depression and anxiety remission in insomnia patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI